<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Richardson</surname>
    <given-names>PG</given-names>
   </name>
   <name>
    <surname>Schlossman</surname>
    <given-names>RL</given-names>
   </name>
   <name>
    <surname>Alsina</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Weber</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>Coutre</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Gasparetto</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Mukhopadhyay</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Ondovik</surname>
    <given-names>MS</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Paley</surname>
    <given-names>CS</given-names>
   </name>
   <name>
    <surname>Lonial</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma</article-title>
  <source>Blood</source>
  <year>2013</year>
  <volume>122</volume>
  <fpage>2331</fpage>
  <lpage>2337</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2013-01-481325</pub-id>
  <pub-id pub-id-type="pmid">23950178</pub-id>
 </element-citation>
</ref>
